CN104544047B - A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof - Google Patents
A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof Download PDFInfo
- Publication number
- CN104544047B CN104544047B CN201410764281.8A CN201410764281A CN104544047B CN 104544047 B CN104544047 B CN 104544047B CN 201410764281 A CN201410764281 A CN 201410764281A CN 104544047 B CN104544047 B CN 104544047B
- Authority
- CN
- China
- Prior art keywords
- sodium ascorbate
- orange
- juice
- buccal tablet
- former
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 title claims abstract description 52
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 title claims abstract description 48
- 235000010378 sodium ascorbate Nutrition 0.000 title claims abstract description 48
- 229960005055 sodium ascorbate Drugs 0.000 title claims abstract description 48
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 33
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000005516 engineering process Methods 0.000 title abstract description 11
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 34
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 20
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 17
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 17
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 23
- 239000008187 granular material Substances 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 11
- 239000007779 soft material Substances 0.000 claims description 9
- 235000015203 fruit juice Nutrition 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 40
- 239000000047 product Substances 0.000 description 31
- 230000000694 effects Effects 0.000 description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 16
- 229930003268 Vitamin C Natural products 0.000 description 16
- 235000019154 vitamin C Nutrition 0.000 description 16
- 239000011718 vitamin C Substances 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000006870 function Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000002932 luster Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- -1 ange Species 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000015205 orange juice Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000001379 nervous effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009818 secondary granulation Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of former orange taste sodium ascorbate buccal tablet and preparation method thereof, raw material is made up of the component of following weight portion: orange 500 1500 parts, sodium ascorbate 100 300 parts, isomaltulose 150 350 parts, arabic gum 100 250 parts, Mel 40 150 parts, magnesium stearate 0.5 2 parts.The present invention retains Fructus Citri junoris genuineness and enhances sodium ascorbate function, is a kind of good vitamin replenisher and health product；Production technology is unique, and formed product is good, and technique is simple, easily operates, it is adaptable to industrialized production.
Description
Technical field
The invention belongs to field of health care food, relate to a kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof.
Background technology
Vitamin C, also known as ascorbic acid, is a kind of water soluble vitamins, has the function that ascorbic acid is sick, is just to maintain human body
Often the indispensable material of physiological metabolism, has important physiological function, participates in aminoacid and neurotransmission, collagen egg in human body
White synthesis, it participates in internal hydroxylation reaction, for forming viscous thing institute between skeleton, tooth, connective tissue and non-Epithelial cell
Required, the normal function of tooth, skeleton, blood vessel can be maintained, increase the resistivity to disease, it also has reduction blood capillary
The permeability of pipe, the function stimulating blood coagulation and the increase resistant function etc. to infecting.According to relevant information report vitamin C all kinds of
Crowd has shortage in various degree, when some indispositions occurs in health, just should supplement appropriate vitamin and mineral in time
Matter improves food deficiency disease, and especially person in middle and old age should more pay attention to.Vitamin C has preventive effect to numerous disease, internal
The people that vitamin C is high, is polluting the harmful element such as people re-absorption lead, cadmium, chromium hardly of environmental work；The people smoked is many
Eat and help the resistance improving cell containing ascorbic food, keep the elasticity of blood vessel, eliminate internal nicotine；It is engaged in play
Strong motion and the people of highly intensive labour, these people, because of too much meeting large losses vitamin C of sweating, should be supplemented in time；Dimension is raw
Element C Wheat Protein, vitimin supplement C can suppress the generation of pigmented spots, promotes that it disappears；Aspirin, sleeping
Medicine, anticancer change medicine, tetracycline, calcium product, contraceptive, depressor etc., all can make body vitamin C reduce, and can cause
Other untoward reaction, should vitimin supplement C in time.
Vitamin C is clinical basic common drug, is widely used in multiple disease prevention and treatment, owing to vitamin C is water-soluble
Liquid pH value is close to about 2, and therefore, acidity is relatively big, orally uses oral cavity, throat esophagus and gastric stimulation relatively big, no
Preferably long-term taking, is also not suitable for taking with acidic drug simultaneously, by a definite limitation on using.And sodium ascorbate is dimension life
The sodium salt of element C, aqueous ph value is close to neutral, and its effect is identical with ascorbic acid, but owing to being sodium salt, so performance is more
Stable, no longer there is ascorbic highly acid simultaneously, can take with multi-medicament for a long time, better than vitamin C simultaneously.Dimension
Raw element C sodium belongs to domestic and international widely used vitamin C intensified dose, the most progressively substitutes vitamin C and uses.
Fructus Citri junoris is the fruit of Rutaceae citrus plant orange, and fruit can eat its sarcocarp raw with peeling, and sarcocarp is also used as other
The additament of food.Its fruit juice taste is sweet and fragrant, containing substantial amounts of sugared and a certain amount of citric acid and abundant vitamin C,
Nutritive value is higher, and fruit also containing Citrin, has high pharmaceutical value.According to nutritionist analysis, the vitality of Fructus Citri junoris
Index is 13.8750, and disease prevention index is 132.50.Fructus Citri junoris rich in hesperidin, citric acid, malic acid, succinic acid, saccharide,
The active substance such as pectin and vitamin, nature and flavor acid, cool.Australian Union's science and industrial research tissue find, it can be pre-
Anti-oral cavity, the cancer of esophagus stomach function regulating occur；It can also make the incidence rate of apoplexy reduce by 19%, and Fructus Citri junoris is counted as traditionally
It is ascorbic mainly for originating in the middle of Western diet, is also provided that the ore deposit such as a considerable amount of carotene and potassium, calcium, ferrum
Material.According to another one research institution's research display of the U.S., orange juice can increase the content of internal high density lipoprotein (HDL), from
And reduce the probability suffered from a heart complaint, because the vitamin C in Fructus Citri junoris can suppress cholesterol to be converted into bile acid in liver, from
And making the lowering of concentration of bile cholesterol, both assemble the chance also the most corresponding minimizing forming cholelithiasis；Dermal melanin can be made
Calm minimizing, thus reduce black speck and freckle, make whitening skin；Contribute to recovering skin elasticity, prevent anaphylactoid generation；
The formation of carcinogen can be suppressed, moreover it is possible to soften and protect.Additionally, pectin contained in Pericarpium Citri junoris can also promote that food leads to
Cross gastrointestinal tract, make cholesterol excrete with feces quickly, to reduce the absorption of cholesterol, can promote that HDL increases, and
The low density lipoprotein, LDL (LDL) transporting " bad " arrives external, blood vessel, and blood circulation promoting reduces cholesterol and blood fat.If
Only its health-care effect of extracting orange juice will be had a greatly reduced quality because processing orange juice during, vitamin C, Flavonoid substances and
Carotenoid loss is a lot, and other dietary fibers beyond pectin are almost with regard to total loss.
Mel, main component is trace element and the inorganic salts such as fructose (molecular formula is C6H12O6), water, the most a small amount of copper ferrum calcium,
Being the highly finished product of the glucide that Apis is led in honeycomb, nature and flavor are sweet, flat, enter lung, spleen, large intestine channel.There is blood pressure lowering, protect
The nutriment of delicious food is not only by the effect Mel such as liver, alleviating pain, and is to treat multiple disease, strong health and benefit of prolonging life
The medicine in longevity.Mel is particularly advantageous for the child of somagenic need high heat and the food being prone to digestion, and it can promote appetite, carries
High metabolic, makes people's spirit strong refreshing and full of physical strength, improves the body resistance to disease.
Isomaltulose, because will not cause the secretion of insulin after its digested absorption, also would not cause swashing of LPL activity
Living and act on, so the existence of isomaltulose makes oils and fats be not easy to be absorbed in fatty tissue, isomaltulose can also improve
Mental concentration is releived nervous effect, and it can not be caused the microorganism of decayed tooth to utilize by oral cavity, the most also would not produce insoluble
Property polydextrose, isomaltulose not only itself will not cause decayed tooth, more has the decayed tooth effect that caused by sucrose of suppression.
At present, domestic and international market also has sodium vitamin C formulation to list, mainly the dosage form such as capsule, masticatory, buccal tablet, product
Plant less, and be substantially the addition additive such as essence, pigment, be not suitable for long-term taking, and its composition is more single, protect
Health-care function is poor.Now it is badly in need of a kind of instant of exploitation, is of high nutritive value, easily stores and take, and can be with long-term taking product.
Find by retrieving domestic and international prior art, there is presently no based on orange and sodium ascorbate, Mel, isomaltulose
The report of former orange taste sodium ascorbate buccal tablet prepared by material.Based on above theoretical and Shortcomings, this patent is solving many technology
Develop former orange taste sodium ascorbate buccal tablet on the basis of problem, be of high nutritive value, pure in mouth feel, safe without toxic side effect,
Processing technique is relatively easy, is easier to realize industrialization and produces.
Summary of the invention
Present invention is to provide a kind of effective, former orange taste sodium ascorbate buccal tablet of taking convenience, pure taste, and
Prepare the preparation method of this buccal tablet.This product has ascorbic acid disease, antioxidation, antitumor, reduction lipid peroxidation, carries
The effects such as high immunity of organisms, cough-relieving wet one's whistle, can be used for prevention and auxiliary treatment vitamin C deficiency and various acute and chronic infect disease or
Other diseases with enhancing body resistance, convalescent period During Wound Healing and the health therapy of anaphylactic disease after being ill.
The present invention former orange taste sodium ascorbate buccal tablet uses Fructus Citri junoris fresh goods to squeeze natural juice, after marc adds isomaltulose vacuum drying
Being ground into fruit powder, it retains the distinctive color of Fructus Citri junoris and abnormal smells from the patient, it is not necessary to add pigment and essence again.Fructus Citri junoris fruit powder add Mel, Ah
Using orange juice repeatedly to pelletize after drawing primary glue, granule adds sodium ascorbate tabletting, makes former orange taste sodium ascorbate buccal tablet,
The present invention improves product original flavor, mouthfeel and health care, and it can make buccal tablet forming, and outward appearance is beautiful, and mouthfeel is good.
The present invention overcomes correlation technique difficult point by screening science prescription composition and unique preparation technology, prepares by this method
Product, had both kept the effective ingredient of former Fructus Citri junoris, local flavor and color and luster, and raising product was medicinal and health value, and vitamin C
Sodium pH value is close to neutral, and it can alleviate acid stimulation, it is easy to product is sucked.Primary raw material sodium ascorbate tool in prescription of the present invention
Having stronger clinical function, it can be used for a variety of causes and causes vitamin C deficiency to prevent it can also be used to hypovitaminosis C is clinical
The treatment of disease, simultaneously because its PH is close to neutral, selects it to make buccal tablet mouthfeel more preferable, and zest is less.Due to directly
Using the sub-natural juice of orange to pelletize, it increases the active substance content such as vitamin C, and containing Fructus Citri junoris primary colors and peculiar fragrance, therefore,
Without adding pigment and essence in prescription, greatly retain color and luster and the local flavor of former Fructus Citri junoris, embody product the original taste of Fructus Citri junoris and
Abnormal smells from the patient, strengthens Product Safety.Preparation technology the most of the present invention is easy, it is adaptable to industrialized production, and product taking convenience
Safety, effect are the best, genuine, are suitable for various people's long-term taking.
Technical solution of the present invention is:
A kind of former orange taste sodium ascorbate buccal tablet, raw material is made up of the component of following weight portion: orange 500-1500 part, dimension
Raw element C sodium 100-300 part, isomaltulose 150-350 part, arabic gum 100-250 part, Mel 40-150 part, tristearin
Acid magnesium 0.5-2 part.
The above former orange taste sodium ascorbate buccal tablet, raw material is preferably made up of the component of following weight portion: the sub-800-1200 of orange
Part, sodium ascorbate 150-250 part, isomaltulose 200-300 part, arabic gum 150-200 part, Mel 70-120
Part, magnesium stearate 1-1.5 part.
The above former orange taste sodium ascorbate buccal tablet, raw material is the most preferably made up of the component of following weight portion: orange 1000
Part, sodium ascorbate 200 parts, isomaltulose 150 parts, arabic gum 175 parts, Mel 95 parts, magnesium stearate 1.0
Part.
The preparation method of the above former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: orange 500-1500 part, sodium ascorbate 100-300 part, isomaltulose
150-350 part, arabic gum 100-250 part, Mel 40-150 part, magnesium stearate 0.5-2 part.
2. take orange, clean, remove the peel, remove seed, put and juice extractor squeezes natural juice, fruit juice centrifuge or the filter of 200-300 mesh
Net point takes normal juice, standby；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, be dried to moisture content 3-10%, be ground into composite fruit
Slag fine powder, crosses 200-300 mesh sieve, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris natural juice that step 2 obtains
Liquid, soft material processed, to pelletize, be dried, granulate, granule adds sodium ascorbate, magnesium stearate, mix homogeneously, tabletting, to obtain final product.
The preparation method of the above former orange taste sodium ascorbate buccal tablet, the granulation step in described step 4 preferably employs repeatedly
Method of granulating: pulverize after making particle drying for the first time, then use Fructus Citri junoris normal juice multi granulating；And particle drying uses vacuum
Drying means, baking temperature is 40 DEG C-60 DEG C.
The preparation method of the above former orange taste sodium ascorbate buccal tablet, the granulation step in described step 4 can be first by step
The Fructus Citri junoris normal juice obtained in 2 is condensed into appropriate concentrated solution, is used for pelletizing.
The preparation method of the above former orange taste sodium ascorbate buccal tablet, described step 3 drying steps preferably employs vacuum drying
Method, baking temperature is 40 DEG C-60 DEG C.
Being squeezed the juice by orange in the technique of the present invention technology, it can retain the distinctive effective ingredient of Fructus Citri junoris, fragrance and color and luster, Er Qieguo
Slag adds isomaltulose and uses super micron mill to pulverize after drying, and adds Mel soft material, the products taste exquisiteness of preparation,
Fresh and sweet, more embody the genuineness of product.Production technology of the present invention is unique, and formed product is good, and technique is simple, easily operates,
Can be suitably used for industrialized production.
Characteristic scientific and reasonable screening adjuvant according to sodium ascorbate and proportioning in inventive formulation, in order to solve preparations shaping and product
The difficult problems such as product mouthfeel, select arabic gum and Mel as combination adhesive in preparations shaping, and they not only have stronger gluing
Putting forth effort and soft elasticity, make product color good, outward appearance is beautiful, also has enhancing product trophic function.Arabic gum is a kind of
The natural plants hydrosol, it does not the most produce heat, is good water soluble dietary fiber, and medically arabic gum also has
Reduce the function of Blood Cholesterol；And in order to improve mouthfeel and the outward appearance of product, keep product lubricity and Fructus Citri junoris fragrance, adopt
With having the Mel of good performance of keeping humidity, it can make product keep certain moisture, prevents from being dried, and owing to it is non-volatile
Polyhydric alcohol, keeping the special aromatic function of product so also having, strengthening mouthfeel and the aroma effect of product.Meanwhile, in order to change
Kind Fructus Citri junoris is acid and sweet taste is inadequate, uses and add appropriate isomaltulose sweeting agent and strengthen mouthfeel and promotion promotes the production of body fluid in this prescription
Effect, beneficially diabetes patient are taken, and improve product function.
In order to reach the effect above, inventor has done substantial amounts of experiment, and part research conditions is as follows:
One, binding agent screening
In order to solve preparations shaping problem, dextrin, sodium carboxymethyl cellulose, gelatin, slurry glucose, polyethylene are tried out
The binding agents such as ketopyrrolidine, but because mouthfeel or granulation and molding effect are bad and abandon, finally determine and select in preparations shaping
Arabic gum and Mel, as combination adhesive, are shown in Table 1.
Table 1 binding agent the selection result table (unit: g)
The above results shows, formula 1,7 weak effect, it is impossible to be used for producing, and formula 2-6 molding effect is preferable, can be used for big raw
Producing, wherein formula 4 effect is best, and mouthfeel is good.
Two, sweeting agent screening
Test is tried out sucrose, stevioside, saccharin sodium, xylitol, maltose alcohol etc., has been shown in Table 2.
Table 2 sweeting agent the selection result table (unit: g)
Remarks: "+" the most, effect is the best.
Above-mentioned result of the test shows, selects isomaltulose to do sweeting agent mouthfeel best, gentle fine and smooth.And have certain binding agent
Effect, hygroscopicity is the lowest, is beneficial to storage.
In a word, the present invention passes through lot of experiments, is preferably adapted for the characteristic supplementary material composition of sodium ascorbate, and prescription forms science,
Technique is unique, it is not necessary to add the industrial chemicals such as pigment, essence, and product safety performance is high.The buccal tablet made by this prescription, in good taste,
Taking convenience, retains Fructus Citri junoris genuineness and enhances sodium ascorbate function, being a kind of good vitamin replenisher and health care
Product.Meanwhile, the prescription composition of the present invention is easy, science, and product bioavailability is high, effective, is suitable for various people long-term
Take.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but is not intended to protection scope of the present invention and range of application:
One, the preparation method of former orange taste sodium ascorbate buccal tablet
Embodiment 1
The preparation method of a kind of former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: the sub-50kg of orange, sodium ascorbate 10kg, isomaltulose 15kg, Arab
Glue 10kg, Mel 4kg, magnesium stearate 0.05kg.
2. taking orange, clean, remove the peel, remove seed, put and squeeze natural juice in juice extractor, fruit juice centrifuge divides and takes normal juice, standby
With；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, use boulton process 80 DEG C to be dried to moisture content 3%,
Pulverize with high energy nanometer impact grinding, cross 200 mesh sieves, fail to be pulverized again by the powder body of sieve, after 200 mesh sieves,
Micropowder mixing after sieving, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris natural juice that step 2 obtains
Liquid, mixes soft material processed, pelletizes, and granule is at 80 DEG C of vacuum drying, granulate, and granule adds sodium ascorbate, magnesium stearate, mixed
Close uniformly, tabletting, to obtain final product.
Embodiment 2
The preparation method of a kind of former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: the sub-80kg of orange, sodium ascorbate 15kg, isomaltulose 20kg, Arab
Glue 15kg, Mel 7kg, magnesium stearate 0.1kg.
2. taking orange, clean, remove the peel, remove seed, put and squeeze natural juice in juice extractor, fruit juice divides with 300 mesh filter screens and takes normal juice,
Standby；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, use boulton process 40 DEG C to be dried to moisture content 10%,
Pulverize with high energy nanometer impact grinding, cross 300 mesh sieves, fail to be pulverized again by the powder body of sieve, after 300 mesh sieves,
Micropowder mixing after sieving, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris natural juice that step 2 obtains
Liquid, mixes soft material processed, pelletizes, and granule is at 40 DEG C of vacuum drying, granulate, and granule adds sodium ascorbate, magnesium stearate, mixed
Close uniformly, tabletting, to obtain final product.
Embodiment 3
The preparation method of a kind of former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: the sub-120kg of orange, sodium ascorbate 25kg, isomaltulose 30kg, Arab
Glue 20kg, Mel 12kg, magnesium stearate 0.15kg.
2. taking orange, clean, remove the peel, remove seed, put and squeeze natural juice in juice extractor, fruit juice divides with 300 mesh filter screens and takes normal juice,
Standby；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, use boulton process 60 DEG C to be dried to moisture content 5%,
Pulverize with high energy nanometer impact grinding, cross 300 mesh sieves, fail to be pulverized again by the powder body of sieve, after 300 mesh sieves,
Micropowder mixing after sieving, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris natural juice that step 2 obtains
Liquid, mixes soft material processed, pelletizes, and granule, 60 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then used remaining orange
Sub-normal juice is pelletized, until Fructus Citri junoris normal juice is finished, and granulate, granule addition sodium ascorbate, magnesium stearate, mix homogeneously,
Tabletting, to obtain final product.
Embodiment 4
The preparation method of a kind of former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: the sub-150kg of orange, sodium ascorbate 30kg, isomaltulose 35kg, Arab
Glue 25kg, Mel 15kg, magnesium stearate 0.20kg.
2. taking orange, clean, remove the peel, remove seed, put and squeeze natural juice in juice extractor, fruit juice divides with 300 mesh filter screens and takes normal juice,
60 DEG C of concentrating under reduced pressure become appropriate concentrated solution, standby；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, use boulton process 60 DEG C to be dried to moisture content 8%,
Pulverize with high energy nanometer impact grinding, cross 300 mesh sieves, fail to be pulverized again by the powder body of sieve, after 300 mesh sieves,
Micropowder mixing after sieving, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris that step 2 obtains concentrates
Liquid, mixes soft material processed, pelletizes, and granule is at 60 DEG C of vacuum drying, granulate, and granule adds sodium ascorbate, magnesium stearate, mixed
Close uniformly, tabletting, to obtain final product.
Embodiment 5
The preparation method of a kind of former orange taste sodium ascorbate buccal tablet, comprises the following steps:
1. weigh raw material by following weight portion: the sub-100kg of orange, sodium ascorbate 20kg, isomaltulose 15kg, Arab
Glue 17.5kg, Mel 9.5kg, magnesium stearate 0.15kg.
2. taking orange, clean, remove the peel, remove seed, put and squeeze natural juice in juice extractor, fruit juice divides with 300 mesh filter screens and takes normal juice,
Standby；
3. take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, use boulton process 50 DEG C to be dried to moisture content 6%,
Pulverize with high energy nanometer impact grinding, cross 300 mesh sieves, fail to be pulverized again by the powder body of sieve, after 300 mesh sieves,
Micropowder mixing after sieving, obtains compound orange powder；
4. take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris natural juice that step 2 obtains
Liquid, mixes soft material processed, pelletizes, and granule, 50 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then used remaining orange
Sub-normal juice is pelletized, until Fructus Citri junoris normal juice is finished, and granulate, granule addition sodium ascorbate, magnesium stearate, mix homogeneously,
Tabletting, to obtain final product.
Two, subjective appreciation
By above-mentioned 5 the embodiment samples prepared, allow 50 people foretaste respectively, carry out sense organ investigation evaluation.Evaluation project
Having: buccal tablet structural state, color and luster, local flavor, mouthfeel, recycling weighting method calculates total score, and structural state weight coefficient is 0.2,
Color and luster weight coefficient is 0.2, and local flavor weight coefficient is 0.3, mouthfeel weight coefficient, 0.3, the results are shown in Table 3.
Table 3 buccal tablet results of sensory evaluation table
Above-mentioned result of the test shows, 5 embodiment samples that the present invention prepares, and subjective appreciation is effective, and weight score is
More than 7 points.Illustrate that the present invention can retain the distinctive effective ingredient of Fructus Citri junoris, fragrance and color and luster, and marc adds isomaltulose
Dried employing super micron mill is pulverized, and adds Mel soft material, and the products taste of preparation is fine and smooth, fresh and sweet, retains Fructus Citri junoris former
Juice original flavor and enhance sodium ascorbate function, is a kind of good vitamin replenisher and health product；Use Fructus Citri junoris normal juice many
Secondary granulation, and particle drying employing vacuum drying method, obtained buccal tablet fragrance is stronger, and rate of drying is the most very fast.
Production technology of the present invention is unique, and formed product is good, and technique is simple, easily operates, can be suitably used for industrialized production.
Claims (3)
1. the preparation method of a former orange taste sodium ascorbate buccal tablet, it is characterised in that comprise the following steps:
(1) raw material is weighed by following weight portion: orange 500-1500 part, sodium ascorbate 100-300 part, isomaltulose
150-350 part, arabic gum 100-250 part, Mel 40-150 part, magnesium stearate 0.5-2 part;
(2) take orange, clean, remove the peel, remove seed, put and juice extractor squeezes natural juice, fruit juice centrifuge or 200-300 mesh filter screen
Divide and take normal juice, standby；
(3) take above-mentioned Fructus Citri junoris marc, add isomaltulose, mix homogeneously, be dried to moisture content 3-10%, be ground into composite fruit
Slag fine powder, crosses 200-300 mesh sieve, obtains compound orange powder；
(4) take above-mentioned compound orange powder, add arabic gum, mix homogeneously, add Mel and Fructus Citri junoris that step (2) obtains is former
Juice, soft material processed, to pelletize, be dried, granulate, granule adds sodium ascorbate, magnesium stearate, mix homogeneously, tabletting, to obtain final product.
The preparation method of the most former orange taste sodium ascorbate buccal tablet, it is characterised in that described step (4)
In granulation step use multi granulating method: make for the first time and pulverize after particle drying, then use Fructus Citri junoris normal juice multi granulating；
And particle drying uses vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
The preparation method of the most former orange taste sodium ascorbate buccal tablet, it is characterised in that described step (3)
Drying steps uses vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764281.8A CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764281.8A CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104544047A CN104544047A (en) | 2015-04-29 |
| CN104544047B true CN104544047B (en) | 2016-08-24 |
Family
ID=53061969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410764281.8A Expired - Fee Related CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104544047B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373479A (en) * | 2017-06-21 | 2017-11-24 | 防城港圣保堂制药有限公司 | A kind of ion VC compositions containing navel orange and preparation method thereof |
| CN107496645A (en) * | 2017-08-11 | 2017-12-22 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing Chinese yam and preparation method thereof |
| CN107455699A (en) * | 2017-08-11 | 2017-12-12 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing pawpaw and preparation method thereof |
| CN108175104A (en) * | 2018-01-18 | 2018-06-19 | 广东健林生物科技有限公司 | A kind of homovitamin C content chewable tablets and preparation method thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1256088C (en) * | 2003-12-12 | 2006-05-17 | 黄爱强 | Vitamin C sodium capsule |
| CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
| CN102178216B (en) * | 2010-12-08 | 2012-09-19 | 叶建斌 | Formula of fruit chewable tablet for antiallergic skin care and preparation method thereof |
| CN102228180B (en) * | 2011-07-12 | 2013-04-03 | 中国热带农业科学院椰子研究所 | Betelnut buccal tablet and preparation method thereof |
| KR20130039853A (en) * | 2011-10-13 | 2013-04-23 | 농업회사법인 주식회사 헬스페이스 | Method for extracting rubus coreanus miquel, method for preparing drink and tablet containing the same |
| CN102429150A (en) * | 2011-12-15 | 2012-05-02 | 广东汤臣倍健生物科技股份有限公司 | Vitamin C chewable tablets for enhancing human immunity |
| CN103652939B (en) * | 2012-08-30 | 2015-04-01 | 高宜 | Capsule with multiple vitamins C |
| CN103110105A (en) * | 2012-11-14 | 2013-05-22 | 江苏江山制药有限公司 | Production method for food additive sugar-free vitamin C sodium salt particles |
| CN103190620A (en) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | Vitamin C lozenge and preparation method thereof |
| KR101468625B1 (en) * | 2013-11-29 | 2014-12-03 | 농업회사법인 주식회사 헬스페이스 | Method for extracting rubus coreanus miquel, method for preparing drink and tablet containing the same |
| CN103750182A (en) * | 2013-12-05 | 2014-04-30 | 福建南海食品有限公司 | Honey pomelo powder buccal tablet and preparation method thereof |
| CN103960611B (en) * | 2014-05-06 | 2016-07-06 | 恩施州益寿果业股份有限公司 | A kind of rich in ascorbic compound Fructus actinidiae chinensis buccal tablet and preparation method |
-
2014
- 2014-12-11 CN CN201410764281.8A patent/CN104544047B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104544047A (en) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104524110B (en) | A kind of Chinese medicine composition with invigorating the spleen to clear away damp pathogen effect | |
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN103463457B (en) | Composite chewable tablet of Herba Dendrobii Hericium erinaceus (Bull. Ex Fr.) Pers. and preparation method thereof | |
| CN104605224A (en) | Original pineapple flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN104546955A (en) | Raw kiwifruit flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN104544047B (en) | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof | |
| CN105494844A (en) | Production method of Chinese wolfberry fruit tablet candy | |
| CN104286273A (en) | Application of dendrobium candidum and tea leaf product thereof | |
| KR20170142756A (en) | composition and method thereof | |
| CN105028995A (en) | Mixed dog food and preparation method thereof | |
| CN107751778A (en) | A kind of high microsteping content health caring noodles with effects for removing toxic heat and preparation method thereof | |
| CN104544048A (en) | Buccal tablet with composite vitamin C sodium and preparation method thereof | |
| CN105994740A (en) | Green tea with dendrobium officinale and method for preparing green tea | |
| CN107432343A (en) | A kind of jasmine tea beverage and preparation method thereof | |
| CN104305229B (en) | A kind of stem of noble dendrobium dietary fiber food and its processing method | |
| CN104605223A (en) | Original strawberry flavor vitamin C sodium buccal tablet and preparation process thereof | |
| KR101160196B1 (en) | Functional food and method of preparing thereof | |
| CN104544049A (en) | Vitamin C sodium lozenge and preparation process thereof | |
| CN107375509A (en) | It is a kind of to be used to improve immunity, the health food of pre- anti-cancer | |
| CN103125931A (en) | Novel energy replenisher | |
| CN105851336A (en) | Dendrobium officinale tea and preparation method thereof | |
| CN104605280A (en) | Snow pear-containing buccal tablet and preparation technology thereof | |
| CN105535756A (en) | A traditional Chinese medicine composition helping digestion and sleeping for infants, a preparing method thereof and a preparation of the composition | |
| CN104544114A (en) | Multivitamin buccal tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160720 Address after: 530000 Guangxi Nanning Qingxiu District 24 building room 2110 Applicant after: GUANGXI NANNING ZHICUI TECHNOLOGY CONSULTING CO., LTD. Address before: Lake 530022 Nanning Road, No. 4 the Guangxi Zhuang Autonomous Region Lake District 38 Building 2 unit 101 room Applicant before: Zhang Shenman Applicant before: Wei Lingju |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ding Xiangdong Inventor before: Zhang Shenman Inventor before: Wei Lingju |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170524 Address after: Yao Chong Street Road in Qixia District of Nanjing city of Jiangsu Province, No. 1 210046 Patentee after: Jiangsu Handian biological Polytron Technologies Inc Address before: 530000 Guangxi Nanning Qingxiu District 24 building room 2110 Patentee before: GUANGXI NANNING ZHICUI TECHNOLOGY CONSULTING CO., LTD. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20181211 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |